Entyvio (Takeda Pharmaceuticals America, Inc.)
Welcome to the PulseAid listing for the Entyvio drug offered from Takeda Pharmaceuticals America, Inc.. This Integrin Receptor Antagonist [EPC],Integrin Receptor Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Takeda Pharmaceuticals America, Inc. |
| NON-PROPRIETARY NAME: | vedolizumab |
| SUBSTANCE NAME: | VEDOLIZUMAB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Integrin Receptor Antagonist [EPC],Integrin Receptor Antagonists [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2014-05-20 |
| END MARKETING DATE: | 0000-00-00 |
Entyvio HUMAN PRESCRIPTION DRUG Details:
| Item Description | Entyvio from Takeda Pharmaceuticals America, Inc. |
| LABELER NAME: | Takeda Pharmaceuticals America, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 300(mg/5mL) |
| START MARKETING DATE: | 2014-05-20 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 64764-300_6e94621c-1a95-4af9-98d1-52b9e6f1949c |
| PRODUCT NDC: | 64764-300 |
| APPLICATION NUMBER: | BLA125476 |
Other VEDOLIZUMAB Pharmaceutical Manufacturers / Labelers:
